01 42Care4 Aps
02 15Abacus Medicine A/S
03 1Amryt Pharmaceuticals Dac
04 4BIOINDUSTRIA L.I.M. SpA
05 1BIOINDUSTRY ITALIAN LABORATORY MEDICINALI SPA
06 3CHEMI SPA
07 3CHEMI SpA
08 4Campus Pharma Ab
09 1Camurus Ab
10 1Cc Pharma Nordic Aps
11 3Central Procurement & Supplies Unit
12 2Cherubino Limited
13 9Cross Pharma Ab
14 1EJ Busuttil Ltd
15 3Ebb Medical Ab
16 1Farmak JSC
17 1Farmak Sa
18 3Fresenius Kabi Ab
19 3Fresenius Kabi Limited
20 3Gp Pharm
21 4Gp Pharm Sa
22 4HOSPIRA ITALIA Srl
23 7ITALFARMACO SpA
24 3LIFEPHARMA SPA
25 3LIFEPHARMA SpA
26 4Labatec Pharma Sa
27 1Lyomark Pharma Gmbh
28 15Medartuum Ab
29 3Mepha Pharma Ag
30 3Northern Medical Group Aps
31 4Novartis Baltics Sia
32 5Novartis Ireland Limited
33 2Novartis Pharma Ag
34 6Novartis Pharma Schweiz Ag
35 6Novartis Pharmaceuticals Sa
36 7Novartis Sweden Ab
37 12Orifarm Ab
38 7Paranova Pharmaceuticals Ab
39 4Pfizer Ab
40 2Pfizer Sl
41 3Ratiopharm Espana Sa
42 4SUN PHARMACEUTICAL IND. BV
43 4SUN PHARMACEUTICAL IND.EU.B.V.
44 4Sun Pharmaceutical Industries (Europe) Bv
45 4Sun Pharmaceutical Industries Europe Bv
46 3Teva B.V.
47 6Teva Bv
48 2Teva Sweden Ab
49 2Uab Bijon Medica
01 86Octreotide
02 114Octreotide Acetate
01 1Capsule
02 3Injectable And Infusion Solution
03 3Injectable And Perfusion Solution
04 60Injectable Solution
05 1Octreotide 0.05Mg 10 Units Parenteral Use
06 1Octreotide 0.1Mg 10 Units Parenteral Use
07 1Octreotide 0.5Mg 10 Units Parenteral Use
08 1Octreotide 0.5Mg 3 Units' Parenteral Use
09 5Octreotide 100Mcg 5 Units Parenteral Use
10 1Octreotide 10Mg 1 Unit Parenteral Use
11 4Octreotide 1Mg 1 Unit Parenteral Use
12 1Octreotide 20Mg 1 Unit Parenteral Use
13 1Octreotide 30Mg 1 Unit Parenteral Use
14 4Octreotide 500Mcg 5 Units Parenteral Use
15 5Octreotide 50Mcg 5 Units Parenteral Use
16 3Powder And Solvent For Extended-Release Injectable Suspension
17 7Powder And Solvent For Injectable Suspension
18 6Powder And Solvent For Prolonged-Release Injectable Suspension
19 3Powder And Solvent For Prolonged-Release Suspension For Injection
20 34Powder For Injection
21 1Prolonged Release Solution For Injection
22 1Solution
23 30Solution For Injection
24 4Solution For Injection And Infusion
25 5Solution For Injection In Pre-Filled
26 1Solution For Injection In Pre-Filled Syringe
27 1Solution For Injection Or Concentrate For Solution For Infusion
28 11Solution For Injection/Infusion
29 1Solution for Injection
01 8Estonia
02 36Italy
03 14Malta
04 3Moldova
05 22Spain
06 103Sweden
07 13Switzerland
08 1Ukraine
01 4Longastatina
02 3Longastatina Lar
03 1Mycapssa
04 1OCTREOTIDE BIOINDUSTRY LIM
05 4OCTREOTIDE SUN
06 2Octra
07 2Octreo-Ratiopharm
08 4Octreotida Gp-Pharm
09 2Octreotida Hospira
10 3Octreotida Ratiopharm
11 4Octreotida Sun
12 3Octreotida Teva
13 15Octreotide
14 3Octreotide 2Care4
15 3Octreotide Abacus Medicine
16 2Octreotide Bendalis
17 2Octreotide Bijon
18 4Octreotide Campus
19 3Octreotide Csc
20 3Octreotide Fresenius Kabi
21 4Octreotide Hospira
22 4Octreotide Labatec
23 2Octreotide Orifarm
24 4Octreotide Sun
25 9Octreotide Teva
26 3Octreotide-Mepha LA
27 1Octroflex
28 1Oczyesa
29 2Olatuton
30 3SIROCTID
31 45Sandostatin
32 3Sandostatin LAR Fertigspritzen
33 37Sandostatin Lar
34 3Sandostatina
35 2Sandostatin®
36 3Siroctid
37 3TREOJECT
38 3Treoject
Regulatory Info :
Registration Country : Italy
Brand Name : Siroctid
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes 1 ml 0. 1 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Siroctid
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes 1 ml 0.05 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Longastatina
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Longastatina
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Treoject
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes EV SC 1 ml 0. 1 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Treoject
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes EV SC 1 ml 0.05 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
